Differential effects of pharmacological leukotriene pathway modulators in a human lung tissue explant model

H. Olsson (Gothenburg, Sweden), S. Vollmer (Gothenburg, Sweden), L. Israelsson (Gothenburg, Sweden), J. Lindgren (Gothenburg, Sweden), Z. Jevnikar Rojnik (Gothenburg, Sweden)

Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms
Session: Asthma science: novel targets and mechanisms
Session type: E-poster session
Number: 2903
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Olsson (Gothenburg, Sweden), S. Vollmer (Gothenburg, Sweden), L. Israelsson (Gothenburg, Sweden), J. Lindgren (Gothenburg, Sweden), Z. Jevnikar Rojnik (Gothenburg, Sweden). Differential effects of pharmacological leukotriene pathway modulators in a human lung tissue explant model. 2903

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Anti-fibrotic effects of liver X receptor agonists in human fetal lung fibroblasts
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011

In vivo imaging of NF-kB pathway in acute lung inflammation mouse model can predict a pharmacological response
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011

COX inhibition enhances remodelling processes in human lung fibroblasts
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010

The effects of human lung mast cell products on the synthetic functions of lung fibroblasts
Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung
Year: 2012

Effects of zileuton on leukotriene formation in human blood cells and expression of enzymes in the biosynthetic pathway
Source: Eur Respir J 2006; 28: Suppl. 50, 316s
Year: 2006

Role of EPAC in transmission of ß-adrenoceptor- and EP2-receptor-induced antiproliferative effects in human pulmonary fibroblasts
Source: Annual Congress 2007 - Recent advances in airway smooth muscle biology
Year: 2007



P38 signalling pathway in primary cultures of human bronchial epithelial cells: effects of transforming growth factor-β and pharmacological modulation by budesonide
Source: Eur Respir J 2002; 20: Suppl. 38, 571s
Year: 2002

A novel receptor antagonist, c-027, inhibits airway contraction in human and murine models of allergen, independent of inflammatory mediator release
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009

Effect of muscarinic receptors inhibition on cytokine release and inflammatory cells infiltration in the airway of cat as an animal model for COPD
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012


Composition of the cellular matrix, nutrition, and hypoxia modulate the secretion and activation of collagenases and their inhibitors in human lung cells
Source: Eur Respir J 2001; 18: Suppl. 33, 244s
Year: 2001

Anti-inflammatory efficacy of formoterol via transrepressive mechanisms is independent of the glucocorticoid receptor in human bronchial epithelial cells
Source: Eur Respir J 2004; 24: Suppl. 48, 128s
Year: 2004

Characterization of the Toll-IL-1 pathway gene profile in an in-vitro model of chronic airway inflammation
Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Year: 2007


Different inhaled corticosteroids altered lung microbiome and regulating the expression of PAF receptor as well as the phagocytosis function of macrophage
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019

The epigenetic modulator 5-aza-2’-deoxycytidine reduces the fibrotic response of human lung fibroblasts to TGFß1 in a novel, long term, 3D cell culture system.
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019


EP4 agonist increases myeloid derived suppressor cells activity and reduces airway inflammatory events in a murine model of asthma
Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms
Year: 2020


Evidence for potential autocrine regulation of human airway smooth muscle cell functions by neurokinins: modulation of gene expression by glucocorticoids
Source: Eur Respir J 2003; 22: Suppl. 45, 11s
Year: 2003

PP216 – Glucocorticoids exacerbate TGFß1 mediated fibrotic signalling in lung fibroblasts by inhibition of metalloproteinase expression and activity
Source: ERS Lung Science Conference 2021
Year: 2021

Muscarinic receptors mediate up-regulation of endothelin-1 expression in human lung fibroblasts
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010

Effects of CHF6297, a potent and selective p38a MAPK inhibitor, in murine models of steroid resistant lung inflammation
Source: International Congress 2017 – Towards new anti-inflammatory and anti-fibrotic agents
Year: 2017



Synthetic cannabinoids induce acute lung inflammation via cannabinoid receptor 1 activation
Source: ERJ Open Res, 6 (3) 00121-2020; 10.1183/23120541.00121-2020
Year: 2020